Muutke küpsiste eelistusi

E-raamat: Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches: Workshop Summary

  • Formaat: 442 pages
  • Ilmumisaeg: 20-Sep-2010
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309162326
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 90,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 442 pages
  • Ilmumisaeg: 20-Sep-2010
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309162326
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Recent scientific and technological advances have accelerated our understanding of the causes of disease development and progression, and resulted in innovative treatments and therapies. Ongoing work to elucidate the effects of individual genetic variation on patient outcomes suggests the rapid pace of discovery in the biomedical sciences will only accelerate. However, these advances belie an important and increasing shortfall between the expansion in therapy and treatment options and knowledge about how these interventions might be applied appropriately to individual patients. The impressive gains made in Americans' health over the past decades provide only a preview of what might be possible when data on treatment effects and patient outcomes are systematically captured and used to evaluate their effectiveness. Needed for progress are advances as dramatic as those experienced in biomedicine in our approach to assessing clinical effectiveness. In the emerging era of tailored treatments and rapidly evolving practice, ensuring the translation of scientific discovery into improved health outcomes requires a new approach to clinical evaluation. A paradigm that supports a continual learning process about what works best for individual patients will not only take advantage of the rigor of trials, but also incorporate other methods that might bring insights relevant to clinical care and endeavor to match the right method to the question at hand. The Institute of Medicine Roundtable on Value & Science-Driven Health Care's vision for a learning healthcare system, in which evidence is applied and generated as a natural course of care, is premised on the development of a research capacity that is structured to provide timely and accurate evidence relevant to the clinical decisions faced by patients and providers. As part of the Roundtable's Learning Healthcare System series of workshops, clinical researchers, academics, and policy makers gathered for the workshop Redesigning the Clinical Effectiveness Research Paradigm: Innovation and Practice-Based Approaches. Participants explored cutting-edge research designs and methods and discussed strategies for development of a research paradigm to better accommodate the diverse array of emerging data resources, study designs, tools, and techniques. Presentations and discussions are summarized in this volume.
Summary 1(50)
1 Evidence Development for Healthcare Decisions: Improving Timeliness, Reliability, and Efficiency 51(36)
Introduction,
51(1)
EBM and Clinical Effectiveness Research,
52(8)
Perspectives on Clinical Effectiveness Research,
60(1)
Clinical Effectiveness Research: Past, Present, and Future
60(7)
Harvey V. Fineberg
The Path to Research That Meets Evidence Needs
67(20)
Carolyn M. Clancy
2 Cases in Point: Learning from Experience 87(68)
Introduction,
87(2)
Hormone Replacement Therapy
89(15)
JoAnn E. Manson
Drug-Eluting Coronary Stents
104(11)
Ashley B. Boam
Bariatric Surgery
115(10)
David R. Flum
Antipsychotic Therapeutics
125(9)
Philip S. Wang
M. Alan Brookhart
Soko Setoguchi
Christine Ulbricht
Sebastian Schneeweiss
Cancer Screening
134(21)
Peter B. Bach
3 Taking Advantage of New Tools and Techniques 155(66)
Introduction,
155(2)
Innovative Approaches to Clinical Trials, Robert M. Califf,
157(10)
Innovative Analytic Tools for Large Clinical and Administrative Data bases, Sebastian Schneeweiss,
167(7)
Adaptive and Bayesian Approaches to Study Design, Donald A. Berry and Frank T. McGraw,
174(6)
Simulation and Predictive Modeling, Mark S. Roberts and David M. Eddy,
180(9)
Emerging Genomic Information, Teri A. Manolio,
189(32)
4 Organizing and Improving Data Utility 221(46)
Introduction,
221(1)
The Electronic Health Record and Care Reengineering: Performance Improvement Redefined
222(15)
Ronald A. Paulus
Walter F. Stewart
Albert Bothe
Seth Frazier
Nirav R. Shah
Mark J. Selna
Administrative Databases in Clinical Effectiveness Research
237(5)
Alexander M. Walker
Clinical Effectiveness Research: The Promise of Registries
242(11)
Alan J. Moskowitz
Annetine C. Gelijns
Distributed Data Networks
253(14)
Richard Platt
5 Moving to the Next Generation of Studies 267(56)
Introduction,
267(2)
Large Data Streams and the Power of Numbers
269(7)
Sharon-Lise T. Normand
Observational Studies
276(5)
Wayne A. Ray
Enhancing the Evidence to Improve Practice: Experimental and Hybrid Studies
281(13)
A. John Rush
Accommodating Genetic Variation as a Standard Feature of Clinical Research
294(5)
Isaac Kohane
Phased Introduction and Payment for Interventions Under Protocol
299(8)
Wade M. Aubry
Research Networks
307(16)
Eric B. Larson
Sarah Greene
6 Aligning Policy with Research Opportunities 323(40)
Introduction,
323(2)
Course-of-Care Data
325(6)
Greg Pawlson
Pharmaceutical Industry Data
331(3)
Peter K. Honig
Regulatory Requirements and Data Generation
334(5)
Mark B. McClellan
Ensuring Optimal Use of Data Generated by Public Investment
339(4)
J. Sanford Schwartz
Building the Research Infrastructure
343(10)
Alan M. Krensky
Engaging Consumers
353(10)
Kathy Hudson
Rick E. Borchelt
Shawna Williams
7 Organizing the Research Community for Change 363(18)
Introduction,
363(1)
Increasing Knowledge from Practice-Based Research,
364(1)
Opportunities for Action (Panel Discussion)
365(5)
Mark B. McClellan
Alan M. Krensky
Garry Neil
John Niederhuber
Lewis Sandy
Common Themes,
370(4)
Issues for Possible Roundtable Follow-Up,
374(7)
Appendixes
A Workshop Agenda
381(6)
B Biographical Sketches of Participants
387(22)
C Workshop Attendee List
409